The Goods and Services Tax Council after its 50th meet in New Delhi on Tuesday has agreed to exempt GST on import of cancer drug Dinutuximab, and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases. Currently, the drug attracts a 12% integrated GST.
Recent Posts
- Nadda to launch Aarogya Setu 2.0 and other digital Initiatives for health sector on Monday
- Cyber fraudsters use fake court order to dupe bank into defreezing accounts in Kerala
- PIL in SC seeks national fire and life safety framework for public premises
- Family with disabled minors wins Rs 1.09 cr compensation for 2018 Bihar road crash
- Iran seeks “insurance mechanism” to reduce risks for ships transiting through Hormuz
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits